Free Trial

Patterson Companies (NASDAQ:PDCO) Downgraded to "Hold" Rating by Leerink Partnrs

Patterson Companies logo with Medical background

Leerink Partnrs downgraded shares of Patterson Companies (NASDAQ:PDCO - Free Report) from a strong-buy rating to a hold rating in a research report released on Wednesday morning,Zacks.com reports. Leerink Partnrs also issued estimates for Patterson Companies' Q3 2025 earnings at $0.62 EPS, Q4 2025 earnings at $0.94 EPS, FY2025 earnings at $2.27 EPS, FY2026 earnings at $2.48 EPS, FY2027 earnings at $2.76 EPS and FY2028 earnings at $3.04 EPS.

PDCO has been the topic of several other reports. Robert W. Baird decreased their price target on shares of Patterson Companies from $28.00 to $25.00 and set a "neutral" rating on the stock in a research note on Friday, December 6th. Stifel Nicolaus decreased their target price on shares of Patterson Companies from $25.00 to $24.00 and set a "hold" rating on the stock in a research note on Thursday, December 5th. UBS Group dropped their price target on Patterson Companies from $27.00 to $24.00 and set a "neutral" rating for the company in a research report on Thursday, September 5th. Mizuho began coverage on Patterson Companies in a research report on Wednesday, December 4th. They set a "neutral" rating and a $23.00 price objective on the stock. Finally, JPMorgan Chase & Co. dropped their target price on Patterson Companies from $29.00 to $26.00 and set a "neutral" rating for the company in a report on Thursday, August 29th. Eleven investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $26.24.

View Our Latest Report on Patterson Companies

Patterson Companies Price Performance

Shares of PDCO traded down $0.35 during mid-day trading on Wednesday, hitting $31.05. 2,151,879 shares of the company were exchanged, compared to its average volume of 998,294. The company has a 50 day moving average of $21.30 and a 200-day moving average of $22.83. Patterson Companies has a 1-year low of $19.45 and a 1-year high of $31.79. The stock has a market cap of $2.74 billion, a price-to-earnings ratio of 18.36, a price-to-earnings-growth ratio of 1.69 and a beta of 1.00. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.76 and a current ratio of 1.37.

Patterson Companies (NASDAQ:PDCO - Get Free Report) last issued its quarterly earnings results on Thursday, December 5th. The company reported $0.47 EPS for the quarter, missing the consensus estimate of $0.49 by ($0.02). The firm had revenue of $1.67 billion for the quarter, compared to analysts' expectations of $1.65 billion. Patterson Companies had a return on equity of 19.77% and a net margin of 2.37%. The firm's revenue for the quarter was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.50 earnings per share. Analysts expect that Patterson Companies will post 2.29 EPS for the current fiscal year.

Patterson Companies Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Wednesday, October 16th were paid a $0.26 dividend. This represents a $1.04 annualized dividend and a dividend yield of 3.35%. The ex-dividend date of this dividend was Friday, October 18th. Patterson Companies's dividend payout ratio (DPR) is presently 60.82%.

Insider Buying and Selling

In other Patterson Companies news, CEO Donald Zurbay sold 1,962 shares of the business's stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $23.08, for a total value of $45,282.96. Following the sale, the chief executive officer now owns 222,736 shares of the company's stock, valued at $5,140,746.88. The trade was a 0.87 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.90% of the company's stock.

Institutional Investors Weigh In On Patterson Companies

Institutional investors have recently modified their holdings of the company. Miller Howard Investments Inc. NY increased its stake in Patterson Companies by 2.3% during the 2nd quarter. Miller Howard Investments Inc. NY now owns 19,545 shares of the company's stock worth $471,000 after buying an additional 442 shares during the period. KBC Group NV increased its position in shares of Patterson Companies by 32.7% during the third quarter. KBC Group NV now owns 2,757 shares of the company's stock worth $60,000 after acquiring an additional 680 shares during the period. Hsbc Holdings PLC raised its stake in shares of Patterson Companies by 6.2% in the second quarter. Hsbc Holdings PLC now owns 14,184 shares of the company's stock valued at $341,000 after acquiring an additional 828 shares in the last quarter. LRI Investments LLC boosted its holdings in Patterson Companies by 201.2% in the second quarter. LRI Investments LLC now owns 1,262 shares of the company's stock valued at $30,000 after purchasing an additional 843 shares during the period. Finally, Bfsg LLC grew its stake in Patterson Companies by 8.2% during the 3rd quarter. Bfsg LLC now owns 12,250 shares of the company's stock worth $268,000 after purchasing an additional 925 shares in the last quarter. 85.43% of the stock is owned by institutional investors and hedge funds.

About Patterson Companies

(Get Free Report)

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.

See Also

Analyst Recommendations for Patterson Companies (NASDAQ:PDCO)

→ Vladimir Lenin was right… (From Porter & Company) (Ad)

Should you invest $1,000 in Patterson Companies right now?

Before you consider Patterson Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Patterson Companies wasn't on the list.

While Patterson Companies currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines